NEW YORK, Aug. 6 , 2015 /PRNewswire/ -- The fairness of the proposed acquisition of IPC Healthcare Inc. ("IPCM" or the "Company") by Team Health Holdings, Inc. ("Team Health") is the subject of an investigation by WeissLaw LLP, a national class action, shareholder rights law firm. The investigation focuses on possible breaches of fiduciary duty and other violations of law by the Board of Directors of IPCM for agreeing to sell the Company to Team Health. On August 4, 2015, the Company announced it had reached a definitive agreement for Team Health to acquire IPCM in a transaction valued at approximately $1.6 billion. Under the terms of the agreement, IPCM shareholders will receive $80.25 for each IPCM share they own.
WeissLaw is investigating whether IPCM's Board acted to maximize shareholder. Notably, the Company recently announced positive financial results, reporting net revenues of $184 million in the second quarter of 2015 as compared with $172.2 million in the same period of the previous year, representing a 7% increase year-over-year. Additionally, IPCM, a national physician group which manages the care of patients in hospitals and other medically-related facilities, also reported that patient encounters grew 14% to nearly 2 million encounters.
Given these facts, WeissLaw is investigating whether IPCM's Board acted in the best interests of IPCM's public shareholders by actively shopping the Company to maximize shareholder value. If you own IPCM shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin by telephone at (888) 593-4771 or by email at stockinfo@weisslawllp.com.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com or fill out the form on our website, http://www.weisslawllp.com/contact/report_fraud/.
Attorney Advertising. Past results do not guarantee a similar outcome.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/weisslaw-llp-ipc-healthcare-inc-acquisition-may-not-be-in-the-best-interest-of-ipcm-shareholders-300125064.html
SOURCE WeissLaw LLP
